nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—KIT—thymus cancer	0.747	1	CbGaD
Regorafenib—Sorafenib—MUSK—thymus cancer	0.0087	0.829	CrCbGaD
Regorafenib—EPHA2—pulmonary artery—thymus cancer	0.00768	0.0611	CbGeAlD
Regorafenib—RET—parathyroid gland—thymus cancer	0.0056	0.0446	CbGeAlD
Regorafenib—Hypothyroidism—Octreotide—thymus cancer	0.00313	0.0952	CcSEcCtD
Regorafenib—Nail disorder—Octreotide—thymus cancer	0.00309	0.0943	CcSEcCtD
Regorafenib—FRK—hematopoietic system—thymus cancer	0.00262	0.0209	CbGeAlD
Regorafenib—Endocrine disorder—Octreotide—thymus cancer	0.00242	0.0737	CcSEcCtD
Regorafenib—DDR2—hematopoietic system—thymus cancer	0.00235	0.0187	CbGeAlD
Regorafenib—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00221	0.0672	CcSEcCtD
Regorafenib—FRK—lymphoid tissue—thymus cancer	0.00184	0.0147	CbGeAlD
Regorafenib—Sorafenib—KIT—thymus cancer	0.00179	0.171	CrCbGaD
Regorafenib—DDR2—pituitary gland—thymus cancer	0.00174	0.0139	CbGeAlD
Regorafenib—RET—neck—thymus cancer	0.0017	0.0135	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—thymus cancer	0.00165	0.0132	CbGeAlD
Regorafenib—Gastroenteritis—Octreotide—thymus cancer	0.00164	0.0501	CcSEcCtD
Regorafenib—FGFR2—neck—thymus cancer	0.00161	0.0128	CbGeAlD
Regorafenib—DDR2—thyroid gland—thymus cancer	0.0015	0.012	CbGeAlD
Regorafenib—FLT1—neck—thymus cancer	0.0015	0.0119	CbGeAlD
Regorafenib—RAF1—neck—thymus cancer	0.00149	0.0118	CbGeAlD
Regorafenib—FLT4—hematopoietic system—thymus cancer	0.00143	0.0114	CbGeAlD
Regorafenib—MAPK11—thyroid gland—thymus cancer	0.00142	0.0113	CbGeAlD
Regorafenib—DDR2—lung—thymus cancer	0.00137	0.0109	CbGeAlD
Regorafenib—Dry skin—Octreotide—thymus cancer	0.00134	0.0407	CcSEcCtD
Regorafenib—FLT4—epithelium—thymus cancer	0.00131	0.0104	CbGeAlD
Regorafenib—KDR—neck—thymus cancer	0.00126	0.0101	CbGeAlD
Regorafenib—RET—hematopoietic system—thymus cancer	0.00126	0.0101	CbGeAlD
Regorafenib—BRAF—pituitary gland—thymus cancer	0.00123	0.00981	CbGeAlD
Regorafenib—FGFR2—hematopoietic system—thymus cancer	0.0012	0.00956	CbGeAlD
Regorafenib—EPHA2—hematopoietic system—thymus cancer	0.00118	0.00939	CbGeAlD
Regorafenib—EPHX2—pituitary gland—thymus cancer	0.00118	0.00937	CbGeAlD
Regorafenib—RET—epithelium—thymus cancer	0.00116	0.00919	CbGeAlD
Regorafenib—TEK—hematopoietic system—thymus cancer	0.00115	0.00916	CbGeAlD
Regorafenib—Weight decreased—Octreotide—thymus cancer	0.00114	0.0347	CcSEcCtD
Regorafenib—KIT—neck—thymus cancer	0.00112	0.00892	CbGeAlD
Regorafenib—FLT1—hematopoietic system—thymus cancer	0.00111	0.00886	CbGeAlD
Regorafenib—RAF1—hematopoietic system—thymus cancer	0.00111	0.00881	CbGeAlD
Regorafenib—FGFR2—epithelium—thymus cancer	0.0011	0.00874	CbGeAlD
Regorafenib—PDGFRB—neck—thymus cancer	0.00109	0.00871	CbGeAlD
Regorafenib—EPHA2—epithelium—thymus cancer	0.00108	0.00859	CbGeAlD
Regorafenib—FGFR1—cardiac atrium—thymus cancer	0.00107	0.00853	CbGeAlD
Regorafenib—BRAF—bone marrow—thymus cancer	0.00107	0.00847	CbGeAlD
Regorafenib—BRAF—thyroid gland—thymus cancer	0.00106	0.00845	CbGeAlD
Regorafenib—Hepatobiliary disease—Octreotide—thymus cancer	0.00106	0.0323	CcSEcCtD
Regorafenib—TEK—epithelium—thymus cancer	0.00105	0.00838	CbGeAlD
Regorafenib—FGFR1—pituitary gland—thymus cancer	0.00105	0.00834	CbGeAlD
Regorafenib—PDGFRA—hematopoietic system—thymus cancer	0.00104	0.0083	CbGeAlD
Regorafenib—FLT1—epithelium—thymus cancer	0.00102	0.0081	CbGeAlD
Regorafenib—EPHX2—thyroid gland—thymus cancer	0.00102	0.00808	CbGeAlD
Regorafenib—RAF1—epithelium—thymus cancer	0.00101	0.00805	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—thymus cancer	0.00101	0.00802	CbGeAlD
Regorafenib—UGT1A1—hematopoietic system—thymus cancer	0.000995	0.00792	CbGeAlD
Regorafenib—BRAF—lung—thymus cancer	0.000965	0.00768	CbGeAlD
Regorafenib—KDR—hematopoietic system—thymus cancer	0.000941	0.00749	CbGeAlD
Regorafenib—RET—pituitary gland—thymus cancer	0.000938	0.00746	CbGeAlD
Regorafenib—Cardiac disorder—Octreotide—thymus cancer	0.000935	0.0285	CcSEcCtD
Regorafenib—DDR2—lymph node—thymus cancer	0.000934	0.00743	CbGeAlD
Regorafenib—EPHX2—lung—thymus cancer	0.000922	0.00734	CbGeAlD
Regorafenib—FLT4—bone marrow—thymus cancer	0.000918	0.0073	CbGeAlD
Regorafenib—FLT4—thyroid gland—thymus cancer	0.000916	0.00729	CbGeAlD
Regorafenib—FGFR1—thyroid gland—thymus cancer	0.000903	0.00719	CbGeAlD
Regorafenib—EPHA2—cardiac atrium—thymus cancer	0.000896	0.00713	CbGeAlD
Regorafenib—Alopecia—Octreotide—thymus cancer	0.00089	0.0271	CcSEcCtD
Regorafenib—RET—lymphoid tissue—thymus cancer	0.00089	0.00708	CbGeAlD
Regorafenib—MAPK11—lymph node—thymus cancer	0.000885	0.00704	CbGeAlD
Regorafenib—Malnutrition—Octreotide—thymus cancer	0.000877	0.0267	CcSEcCtD
Regorafenib—EPHA2—pituitary gland—thymus cancer	0.000876	0.00697	CbGeAlD
Regorafenib—TEK—cardiac atrium—thymus cancer	0.000874	0.00696	CbGeAlD
Regorafenib—KDR—epithelium—thymus cancer	0.00086	0.00685	CbGeAlD
Regorafenib—TEK—pituitary gland—thymus cancer	0.000854	0.0068	CbGeAlD
Regorafenib—FLT1—cardiac atrium—thymus cancer	0.000845	0.00673	CbGeAlD
Regorafenib—RAF1—cardiac atrium—thymus cancer	0.00084	0.00669	CbGeAlD
Regorafenib—KIT—hematopoietic system—thymus cancer	0.000834	0.00664	CbGeAlD
Regorafenib—FLT4—lung—thymus cancer	0.000832	0.00662	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—thymus cancer	0.000831	0.00661	CbGeAlD
Regorafenib—FLT1—pituitary gland—thymus cancer	0.000826	0.00657	CbGeAlD
Regorafenib—Tremor—Octreotide—thymus cancer	0.000822	0.025	CcSEcCtD
Regorafenib—RAF1—pituitary gland—thymus cancer	0.000821	0.00653	CbGeAlD
Regorafenib—FGFR1—lung—thymus cancer	0.00082	0.00653	CbGeAlD
Regorafenib—PDGFRB—hematopoietic system—thymus cancer	0.000815	0.00648	CbGeAlD
Regorafenib—Anaemia—Octreotide—thymus cancer	0.000811	0.0247	CcSEcCtD
Regorafenib—TEK—lymphoid tissue—thymus cancer	0.000811	0.00645	CbGeAlD
Regorafenib—RET—thyroid gland—thymus cancer	0.000808	0.00643	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—thymus cancer	0.000784	0.00624	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—thymus cancer	0.000779	0.0062	CbGeAlD
Regorafenib—FGFR2—thyroid gland—thymus cancer	0.000768	0.00611	CbGeAlD
Regorafenib—KIT—epithelium—thymus cancer	0.000762	0.00607	CbGeAlD
Regorafenib—Hypertension—Octreotide—thymus cancer	0.000757	0.0231	CcSEcCtD
Regorafenib—EPHA2—thyroid gland—thymus cancer	0.000755	0.00601	CbGeAlD
Regorafenib—PDGFRB—epithelium—thymus cancer	0.000745	0.00592	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.000742	0.0226	CcSEcCtD
Regorafenib—TEK—thyroid gland—thymus cancer	0.000736	0.00586	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—thymus cancer	0.000734	0.00584	CbGeAlD
Regorafenib—Dry mouth—Octreotide—thymus cancer	0.00073	0.0223	CcSEcCtD
Regorafenib—ABL1—hematopoietic system—thymus cancer	0.000726	0.00578	CbGeAlD
Regorafenib—KDR—cardiac atrium—thymus cancer	0.000715	0.00569	CbGeAlD
Regorafenib—FLT1—thyroid gland—thymus cancer	0.000712	0.00566	CbGeAlD
Regorafenib—Infection—Octreotide—thymus cancer	0.000711	0.0217	CcSEcCtD
Regorafenib—RAF1—bone marrow—thymus cancer	0.00071	0.00565	CbGeAlD
Regorafenib—RAF1—thyroid gland—thymus cancer	0.000708	0.00563	CbGeAlD
Regorafenib—Nervous system disorder—Octreotide—thymus cancer	0.000702	0.0214	CcSEcCtD
Regorafenib—Thrombocytopenia—Octreotide—thymus cancer	0.000701	0.0214	CcSEcCtD
Regorafenib—KDR—pituitary gland—thymus cancer	0.000698	0.00555	CbGeAlD
Regorafenib—FGFR2—lung—thymus cancer	0.000698	0.00555	CbGeAlD
Regorafenib—Skin disorder—Octreotide—thymus cancer	0.000695	0.0212	CcSEcCtD
Regorafenib—EPHA2—lung—thymus cancer	0.000686	0.00546	CbGeAlD
Regorafenib—TEK—lung—thymus cancer	0.000669	0.00532	CbGeAlD
Regorafenib—PDGFRA—thyroid gland—thymus cancer	0.000667	0.00531	CbGeAlD
Regorafenib—KDR—lymphoid tissue—thymus cancer	0.000663	0.00527	CbGeAlD
Regorafenib—BRAF—lymph node—thymus cancer	0.00066	0.00525	CbGeAlD
Regorafenib—FLT1—lung—thymus cancer	0.000647	0.00515	CbGeAlD
Regorafenib—RAF1—lung—thymus cancer	0.000643	0.00512	CbGeAlD
Regorafenib—EPHX2—lymph node—thymus cancer	0.000631	0.00502	CbGeAlD
Regorafenib—Decreased appetite—Octreotide—thymus cancer	0.000622	0.019	CcSEcCtD
Regorafenib—KIT—pituitary gland—thymus cancer	0.000619	0.00492	CbGeAlD
Regorafenib—PDGFRB—cardiac atrium—thymus cancer	0.000619	0.00492	CbGeAlD
Regorafenib—Gastrointestinal disorder—Octreotide—thymus cancer	0.000618	0.0188	CcSEcCtD
Regorafenib—Fatigue—Octreotide—thymus cancer	0.000617	0.0188	CcSEcCtD
Regorafenib—Pain—Octreotide—thymus cancer	0.000612	0.0187	CcSEcCtD
Regorafenib—PDGFRA—lung—thymus cancer	0.000606	0.00482	CbGeAlD
Regorafenib—PDGFRB—pituitary gland—thymus cancer	0.000604	0.00481	CbGeAlD
Regorafenib—KDR—bone marrow—thymus cancer	0.000603	0.0048	CbGeAlD
Regorafenib—KDR—thyroid gland—thymus cancer	0.000602	0.00479	CbGeAlD
Regorafenib—KIT—lymphoid tissue—thymus cancer	0.000587	0.00467	CbGeAlD
Regorafenib—Gastrointestinal pain—Octreotide—thymus cancer	0.000585	0.0178	CcSEcCtD
Regorafenib—PDGFRB—lymphoid tissue—thymus cancer	0.000573	0.00456	CbGeAlD
Regorafenib—FLT4—lymph node—thymus cancer	0.000569	0.00453	CbGeAlD
Regorafenib—Abdominal pain—Octreotide—thymus cancer	0.000566	0.0172	CcSEcCtD
Regorafenib—Body temperature increased—Octreotide—thymus cancer	0.000566	0.0172	CcSEcCtD
Regorafenib—FGFR1—lymph node—thymus cancer	0.000561	0.00446	CbGeAlD
Regorafenib—ABL1—cardiac atrium—thymus cancer	0.000551	0.00439	CbGeAlD
Regorafenib—KDR—lung—thymus cancer	0.000547	0.00435	CbGeAlD
Regorafenib—CYP2C19—hematopoietic system—thymus cancer	0.000539	0.00429	CbGeAlD
Regorafenib—ABL1—pituitary gland—thymus cancer	0.000539	0.00429	CbGeAlD
Regorafenib—KIT—bone marrow—thymus cancer	0.000535	0.00425	CbGeAlD
Regorafenib—KIT—thyroid gland—thymus cancer	0.000533	0.00424	CbGeAlD
Regorafenib—PDGFRB—bone marrow—thymus cancer	0.000522	0.00416	CbGeAlD
Regorafenib—PDGFRB—thyroid gland—thymus cancer	0.000521	0.00414	CbGeAlD
Regorafenib—Asthenia—Octreotide—thymus cancer	0.000514	0.0156	CcSEcCtD
Regorafenib—ABL1—lymphoid tissue—thymus cancer	0.000511	0.00407	CbGeAlD
Regorafenib—RET—lymph node—thymus cancer	0.000502	0.004	CbGeAlD
Regorafenib—Diarrhoea—Octreotide—thymus cancer	0.00049	0.0149	CcSEcCtD
Regorafenib—KIT—lung—thymus cancer	0.000484	0.00385	CbGeAlD
Regorafenib—PDGFRB—lung—thymus cancer	0.000473	0.00376	CbGeAlD
Regorafenib—CYP2C8—hematopoietic system—thymus cancer	0.000471	0.00375	CbGeAlD
Regorafenib—EPHA2—lymph node—thymus cancer	0.000469	0.00373	CbGeAlD
Regorafenib—ABL1—bone marrow—thymus cancer	0.000465	0.0037	CbGeAlD
Regorafenib—ABL1—thyroid gland—thymus cancer	0.000464	0.00369	CbGeAlD
Regorafenib—TEK—lymph node—thymus cancer	0.000457	0.00364	CbGeAlD
Regorafenib—Vomiting—Octreotide—thymus cancer	0.000455	0.0139	CcSEcCtD
Regorafenib—Rash—Octreotide—thymus cancer	0.000451	0.0138	CcSEcCtD
Regorafenib—Dermatitis—Octreotide—thymus cancer	0.000451	0.0137	CcSEcCtD
Regorafenib—Headache—Octreotide—thymus cancer	0.000448	0.0137	CcSEcCtD
Regorafenib—FLT1—lymph node—thymus cancer	0.000442	0.00352	CbGeAlD
Regorafenib—RAF1—lymph node—thymus cancer	0.00044	0.0035	CbGeAlD
Regorafenib—Nausea—Octreotide—thymus cancer	0.000425	0.013	CcSEcCtD
Regorafenib—CYP2B6—hematopoietic system—thymus cancer	0.000422	0.00336	CbGeAlD
Regorafenib—ABL1—lung—thymus cancer	0.000422	0.00336	CbGeAlD
Regorafenib—CYP2C9—hematopoietic system—thymus cancer	0.000418	0.00333	CbGeAlD
Regorafenib—PDGFRA—lymph node—thymus cancer	0.000414	0.0033	CbGeAlD
Regorafenib—KDR—lymph node—thymus cancer	0.000374	0.00297	CbGeAlD
Regorafenib—CYP2C8—pituitary gland—thymus cancer	0.000349	0.00278	CbGeAlD
Regorafenib—ABCG2—pituitary gland—thymus cancer	0.00034	0.0027	CbGeAlD
Regorafenib—KIT—lymph node—thymus cancer	0.000331	0.00264	CbGeAlD
Regorafenib—PDGFRB—lymph node—thymus cancer	0.000324	0.00257	CbGeAlD
Regorafenib—CYP3A4—hematopoietic system—thymus cancer	0.000319	0.00254	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—thymus cancer	0.000297	0.00237	CbGeAlD
Regorafenib—ABCG2—bone marrow—thymus cancer	0.000294	0.00234	CbGeAlD
Regorafenib—ABCG2—thyroid gland—thymus cancer	0.000293	0.00233	CbGeAlD
Regorafenib—ABL1—lymph node—thymus cancer	0.000288	0.00229	CbGeAlD
Regorafenib—ABCG2—lung—thymus cancer	0.000266	0.00212	CbGeAlD
Regorafenib—CYP2B6—lung—thymus cancer	0.000245	0.00195	CbGeAlD
Regorafenib—ABCB1—hematopoietic system—thymus cancer	0.000226	0.0018	CbGeAlD
Regorafenib—ABCB1—epithelium—thymus cancer	0.000206	0.00164	CbGeAlD
Regorafenib—ABCG2—lymph node—thymus cancer	0.000182	0.00145	CbGeAlD
Regorafenib—ABCB1—pituitary gland—thymus cancer	0.000167	0.00133	CbGeAlD
Regorafenib—ABCB1—lymphoid tissue—thymus cancer	0.000159	0.00126	CbGeAlD
Regorafenib—ABCB1—bone marrow—thymus cancer	0.000145	0.00115	CbGeAlD
Regorafenib—ABCB1—thyroid gland—thymus cancer	0.000144	0.00115	CbGeAlD
Regorafenib—ABCB1—lung—thymus cancer	0.000131	0.00104	CbGeAlD
Regorafenib—ABCB1—lymph node—thymus cancer	8.97e-05	0.000714	CbGeAlD
Regorafenib—PDGFRA—DAP12 interactions—AKT1—thymus cancer	4.86e-05	0.000576	CbGpPWpGaD
Regorafenib—PDGFRA—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	4.86e-05	0.000576	CbGpPWpGaD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—AKT1—thymus cancer	4.85e-05	0.000574	CbGpPWpGaD
Regorafenib—FGFR2—B Cell Activation—AKT1—thymus cancer	4.84e-05	0.000573	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR—AKT1—thymus cancer	4.83e-05	0.000572	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TP53—thymus cancer	4.82e-05	0.000571	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR—AKT1—thymus cancer	4.82e-05	0.000571	CbGpPWpGaD
Regorafenib—MAPK11—Metabolism of mRNA—AKT1—thymus cancer	4.8e-05	0.000569	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR in Cancer—AKT1—thymus cancer	4.79e-05	0.000567	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR in Cancer—AKT1—thymus cancer	4.78e-05	0.000566	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—AKT1—thymus cancer	4.77e-05	0.000566	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—AKT1—thymus cancer	4.77e-05	0.000565	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—AKT1—thymus cancer	4.77e-05	0.000565	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—KIT—thymus cancer	4.77e-05	0.000564	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.76e-05	0.000563	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—AKT1—thymus cancer	4.75e-05	0.000563	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—KIT—thymus cancer	4.75e-05	0.000563	CbGpPWpGaD
Regorafenib—KIT—B Cell Activation—AKT1—thymus cancer	4.75e-05	0.000563	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAML2—thymus cancer	4.73e-05	0.00056	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signal transduction—AKT1—thymus cancer	4.72e-05	0.00056	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR—AKT1—thymus cancer	4.7e-05	0.000557	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAML2—thymus cancer	4.69e-05	0.000555	CbGpPWpGaD
Regorafenib—RAF1—Signaling by SCF-KIT—AKT1—thymus cancer	4.68e-05	0.000555	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB2—AKT1—thymus cancer	4.68e-05	0.000554	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 signaling—AKT1—thymus cancer	4.66e-05	0.000551	CbGpPWpGaD
Regorafenib—FGFR2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	4.63e-05	0.000549	CbGpPWpGaD
Regorafenib—RAF1—Disease—MAML2—thymus cancer	4.63e-05	0.000548	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—AKT1—thymus cancer	4.6e-05	0.000545	CbGpPWpGaD
Regorafenib—PDGFRA—Focal Adhesion—AKT1—thymus cancer	4.59e-05	0.000544	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	4.59e-05	0.000543	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	4.59e-05	0.000543	CbGpPWpGaD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	4.58e-05	0.000543	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	4.57e-05	0.000542	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—AKT1—thymus cancer	4.57e-05	0.000541	CbGpPWpGaD
Regorafenib—KIT—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	4.55e-05	0.000539	CbGpPWpGaD
Regorafenib—FGFR1—B Cell Activation—AKT1—thymus cancer	4.51e-05	0.000534	CbGpPWpGaD
Regorafenib—PDGFRA—B Cell Activation—AKT1—thymus cancer	4.5e-05	0.000533	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD8A—thymus cancer	4.5e-05	0.000533	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling of activated FGFR—AKT1—thymus cancer	4.48e-05	0.000531	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—KIT—thymus cancer	4.46e-05	0.000528	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—CD4—thymus cancer	4.44e-05	0.000525	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—AKT1—thymus cancer	4.41e-05	0.000522	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR in disease—AKT1—thymus cancer	4.38e-05	0.000519	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 interactions—AKT1—thymus cancer	4.38e-05	0.000519	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	4.38e-05	0.000519	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.35e-05	0.000515	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—KIT—thymus cancer	4.35e-05	0.000515	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAML2—thymus cancer	4.34e-05	0.000514	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR—AKT1—thymus cancer	4.34e-05	0.000514	CbGpPWpGaD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	4.32e-05	0.000511	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	4.31e-05	0.00051	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR in Cancer—AKT1—thymus cancer	4.3e-05	0.00051	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—AKT1—thymus cancer	4.28e-05	0.000507	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—KIT—thymus cancer	4.28e-05	0.000507	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAML2—thymus cancer	4.27e-05	0.000505	CbGpPWpGaD
Regorafenib—RAF1—Insulin Signaling—AKT1—thymus cancer	4.23e-05	0.000501	CbGpPWpGaD
Regorafenib—RAF1—Downstream signal transduction—AKT1—thymus cancer	4.21e-05	0.000499	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	4.19e-05	0.000496	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR—AKT1—thymus cancer	4.19e-05	0.000496	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB2—AKT1—thymus cancer	4.17e-05	0.000494	CbGpPWpGaD
Regorafenib—RAF1—DAP12 signaling—AKT1—thymus cancer	4.15e-05	0.000491	CbGpPWpGaD
Regorafenib—PDGFRB—Focal Adhesion—AKT1—thymus cancer	4.14e-05	0.00049	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—AKT1—thymus cancer	4.14e-05	0.00049	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD8A—thymus cancer	4.13e-05	0.000489	CbGpPWpGaD
Regorafenib—MAPK11—Metabolism of RNA—AKT1—thymus cancer	4.11e-05	0.000487	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CD4—thymus cancer	4.07e-05	0.000482	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—AKT1—thymus cancer	4.07e-05	0.000482	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD8A—thymus cancer	4.06e-05	0.00048	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—AKT1—thymus cancer	4.05e-05	0.00048	CbGpPWpGaD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	4.05e-05	0.00048	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAML2—thymus cancer	4.05e-05	0.000479	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAML2—thymus cancer	4.04e-05	0.000478	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	4.02e-05	0.000476	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CD4—thymus cancer	4e-05	0.000474	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—KIT—thymus cancer	3.97e-05	0.000471	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CD4—thymus cancer	3.91e-05	0.000463	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—AKT1—thymus cancer	3.9e-05	0.000462	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—AKT1—thymus cancer	3.9e-05	0.000462	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	3.9e-05	0.000462	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—AKT1—thymus cancer	3.88e-05	0.00046	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.88e-05	0.000459	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—AKT1—thymus cancer	3.87e-05	0.000458	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD8A—thymus cancer	3.85e-05	0.000456	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—AKT1—thymus cancer	3.84e-05	0.000455	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD4—thymus cancer	3.84e-05	0.000455	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD8A—thymus cancer	3.84e-05	0.000455	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—AKT1—thymus cancer	3.83e-05	0.000454	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—AKT1—thymus cancer	3.82e-05	0.000452	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—KIT—thymus cancer	3.82e-05	0.000452	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—KIT—thymus cancer	3.82e-05	0.000452	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CD4—thymus cancer	3.8e-05	0.00045	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CD4—thymus cancer	3.79e-05	0.000448	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—AKT1—thymus cancer	3.69e-05	0.000437	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.67e-05	0.000435	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD4—thymus cancer	3.64e-05	0.000432	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAML2—thymus cancer	3.64e-05	0.000431	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD4—thymus cancer	3.64e-05	0.000431	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL2—thymus cancer	3.6e-05	0.000426	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—AKT1—thymus cancer	3.56e-05	0.000422	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—AKT1—thymus cancer	3.5e-05	0.000414	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD8A—thymus cancer	3.46e-05	0.00041	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.46e-05	0.00041	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CD4—thymus cancer	3.41e-05	0.000404	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—IL2—thymus cancer	3.4e-05	0.000402	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—KIT—thymus cancer	3.38e-05	0.0004	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD8A—thymus cancer	3.37e-05	0.000399	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CD4—thymus cancer	3.32e-05	0.000394	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—AKT1—thymus cancer	3.32e-05	0.000393	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—AKT1—thymus cancer	3.31e-05	0.000392	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD4—thymus cancer	3.28e-05	0.000388	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—AKT1—thymus cancer	3.27e-05	0.000387	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAML2—thymus cancer	3.24e-05	0.000384	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—IL2—thymus cancer	3.11e-05	0.000368	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—KIT—thymus cancer	3.1e-05	0.000367	CbGpPWpGaD
Regorafenib—BRAF—Disease—KIT—thymus cancer	3.09e-05	0.000366	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD8A—thymus cancer	3.08e-05	0.000365	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CD4—thymus cancer	3.04e-05	0.00036	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—AKT1—thymus cancer	2.98e-05	0.000353	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD4—thymus cancer	2.92e-05	0.000346	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—AKT1—thymus cancer	2.91e-05	0.000345	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—KIT—thymus cancer	2.89e-05	0.000342	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—KIT—thymus cancer	2.88e-05	0.000341	CbGpPWpGaD
Regorafenib—FGFR2—Disease—KIT—thymus cancer	2.86e-05	0.000339	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—KIT—thymus cancer	2.69e-05	0.000318	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL2—thymus cancer	2.69e-05	0.000318	CbGpPWpGaD
Regorafenib—FGFR1—Disease—KIT—thymus cancer	2.67e-05	0.000316	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—KIT—thymus cancer	2.66e-05	0.000315	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—AKT1—thymus cancer	2.66e-05	0.000315	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—KIT—thymus cancer	2.6e-05	0.000308	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD4—thymus cancer	2.58e-05	0.000306	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—KIT—thymus cancer	2.54e-05	0.000301	CbGpPWpGaD
Regorafenib—ABL1—Immune System—KIT—thymus cancer	2.53e-05	0.0003	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—AKT1—thymus cancer	2.51e-05	0.000297	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—KIT—thymus cancer	2.4e-05	0.000284	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL2—thymus cancer	2.38e-05	0.000282	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—AKT1—thymus cancer	2.37e-05	0.000281	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD4—thymus cancer	2.37e-05	0.000281	CbGpPWpGaD
Regorafenib—BRAF—Disease—CD4—thymus cancer	2.36e-05	0.00028	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD4—thymus cancer	2.33e-05	0.000276	CbGpPWpGaD
Regorafenib—RAF1—Immune System—KIT—thymus cancer	2.32e-05	0.000274	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TP53—thymus cancer	2.31e-05	0.000274	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—AKT1—thymus cancer	2.21e-05	0.000262	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—thymus cancer	2.21e-05	0.000262	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—thymus cancer	2.21e-05	0.000261	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—thymus cancer	2.19e-05	0.000259	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—KIT—thymus cancer	2.18e-05	0.000259	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL2—thymus cancer	2.18e-05	0.000258	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—thymus cancer	2.18e-05	0.000258	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—KIT—thymus cancer	2.16e-05	0.000256	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—thymus cancer	2.15e-05	0.000255	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—AKT1—thymus cancer	2.14e-05	0.000254	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL2—thymus cancer	2.14e-05	0.000254	CbGpPWpGaD
Regorafenib—RAF1—Disease—KIT—thymus cancer	2.14e-05	0.000253	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	2.05e-05	0.000243	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—thymus cancer	2.04e-05	0.000242	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—thymus cancer	2.04e-05	0.000241	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—thymus cancer	2.03e-05	0.000241	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—AKT1—thymus cancer	2.03e-05	0.000241	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—thymus cancer	2.03e-05	0.00024	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—KIT—thymus cancer	2.01e-05	0.000237	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—AKT1—thymus cancer	2e-05	0.000236	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—thymus cancer	2e-05	0.000236	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—thymus cancer	1.99e-05	0.000235	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—AKT1—thymus cancer	1.95e-05	0.000231	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—AKT1—thymus cancer	1.95e-05	0.000231	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—thymus cancer	1.94e-05	0.000229	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—AKT1—thymus cancer	1.92e-05	0.000227	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—AKT1—thymus cancer	1.89e-05	0.000224	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—thymus cancer	1.89e-05	0.000224	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—AKT1—thymus cancer	1.89e-05	0.000224	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—AKT1—thymus cancer	1.88e-05	0.000222	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—KIT—thymus cancer	1.87e-05	0.000221	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—KIT—thymus cancer	1.86e-05	0.000221	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—AKT1—thymus cancer	1.84e-05	0.000218	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—thymus cancer	1.83e-05	0.000217	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—thymus cancer	1.83e-05	0.000216	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—AKT1—thymus cancer	1.82e-05	0.000215	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—AKT1—thymus cancer	1.81e-05	0.000215	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—thymus cancer	1.79e-05	0.000212	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—thymus cancer	1.78e-05	0.000211	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—thymus cancer	1.78e-05	0.000211	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—thymus cancer	1.77e-05	0.00021	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	1.73e-05	0.000205	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—thymus cancer	1.72e-05	0.000204	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—AKT1—thymus cancer	1.72e-05	0.000203	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—AKT1—thymus cancer	1.7e-05	0.000202	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—AKT1—thymus cancer	1.68e-05	0.0002	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—KIT—thymus cancer	1.68e-05	0.000199	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—AKT1—thymus cancer	1.66e-05	0.000196	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—thymus cancer	1.63e-05	0.000194	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—AKT1—thymus cancer	1.63e-05	0.000194	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—thymus cancer	1.63e-05	0.000193	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—thymus cancer	1.54e-05	0.000182	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—thymus cancer	1.52e-05	0.00018	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—AKT1—thymus cancer	1.52e-05	0.00018	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—KIT—thymus cancer	1.5e-05	0.000177	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—AKT1—thymus cancer	1.46e-05	0.000173	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—AKT1—thymus cancer	1.46e-05	0.000173	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—thymus cancer	1.41e-05	0.000167	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—thymus cancer	1.39e-05	0.000164	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—thymus cancer	1.32e-05	0.000156	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—thymus cancer	1.31e-05	0.000155	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—AKT1—thymus cancer	1.29e-05	0.000153	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—AKT1—thymus cancer	1.28e-05	0.000152	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—thymus cancer	1.21e-05	0.000144	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AKT1—thymus cancer	1.18e-05	0.00014	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—thymus cancer	1.18e-05	0.00014	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKT1—thymus cancer	1.18e-05	0.00014	CbGpPWpGaD
Regorafenib—KIT—Immune System—AKT1—thymus cancer	1.16e-05	0.000138	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—thymus cancer	1.15e-05	0.000136	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AKT1—thymus cancer	1.1e-05	0.000131	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AKT1—thymus cancer	1.1e-05	0.00013	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKT1—thymus cancer	1.09e-05	0.000129	CbGpPWpGaD
Regorafenib—KIT—Disease—AKT1—thymus cancer	1.07e-05	0.000127	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—thymus cancer	1.05e-05	0.000125	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKT1—thymus cancer	1.03e-05	0.000121	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKT1—thymus cancer	1.02e-05	0.000121	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKT1—thymus cancer	1.02e-05	0.00012	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AKT1—thymus cancer	9.91e-06	0.000117	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—thymus cancer	9.87e-06	0.000117	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—thymus cancer	9.78e-06	0.000116	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKT1—thymus cancer	9.69e-06	0.000115	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AKT1—thymus cancer	9.67e-06	0.000115	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AKT1—thymus cancer	9.66e-06	0.000114	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKT1—thymus cancer	9.15e-06	0.000108	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—thymus cancer	9.06e-06	0.000107	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—thymus cancer	8.9e-06	0.000105	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AKT1—thymus cancer	8.83e-06	0.000105	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—thymus cancer	8.45e-06	0.0001	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—thymus cancer	8.42e-06	9.98e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKT1—thymus cancer	8.33e-06	9.87e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKT1—thymus cancer	8.26e-06	9.78e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKT1—thymus cancer	8.16e-06	9.66e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKT1—thymus cancer	7.65e-06	9.06e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—thymus cancer	7.59e-06	8.99e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKT1—thymus cancer	7.51e-06	8.9e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKT1—thymus cancer	7.13e-06	8.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKT1—thymus cancer	7.11e-06	8.42e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AKT1—thymus cancer	7.02e-06	8.32e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AKT1—thymus cancer	7.02e-06	8.32e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—thymus cancer	6.76e-06	8.01e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKT1—thymus cancer	6.41e-06	7.59e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AKT1—thymus cancer	5.96e-06	7.06e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT1—thymus cancer	5.71e-06	6.77e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AKT1—thymus cancer	4.37e-06	5.17e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AKT1—thymus cancer	3.7e-06	4.38e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AKT1—thymus cancer	3.3e-06	3.91e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AKT1—thymus cancer	3.22e-06	3.82e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKT1—thymus cancer	3.01e-06	3.56e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKT1—thymus cancer	1.98e-06	2.35e-05	CbGpPWpGaD
